Skip to content

ECM

Eye Health News

  • Home
  • Conjunctivitis
  • Glaucoma
  • Cataract Surgery
  • Blog
National Vision Announces 2025 Financial Results, Pointing to a ‘Year of Strong Momentum’ DULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., yesterday reported its financial results for the fourth quarter and fiscal year ended January 3, 2026, and provided its outlook for fiscal 2026. For the full fiscal year 2025, National Vision reported “a year of strong momentum,” with…EYECAREMar 05 2026
World Leaders to Convene in Antigua for Inaugural ‘Global Summit for Eye Health’ With IAPB and WHO ST. JOHN’S, Antigua and Barbuda, LONDON—Gaston Browne, prime minister of Antigua and Barbuda, has announced the first ever Global Summit for Eye Health to be held on November 2, 2026, inviting heads of government, ministers and business leaders to convene in St. John’s to prioritize eye health. The Summit, hosted by the government of Antigua…EYECAREMar 05 2026
Eyewear Design Week Gets Underway in NYC With a Focus on Innovation and Trends NEW YORK—Eyewear Design Week, the second annual showcase for the high fashion sector of the North American optical market, got underway in New York City on Wednesday as visitors attended multiple company eyewear showrooms throughout the city to view their latest collections. Eyewear Design Week, scheduled to run from March 4-8, merges together multiple events,…EYECAREMar 05 2026
The Vision Council Appoints Brandon Butler, CEO of Artisan Lab Network, to Its Board of Directors WASHINGTON D.C.—The Vision Council has announced that Brandon Butler, founder and chief executive officer of Artisan Lab Network (ALN)—a multi-lab platform built to strengthen independent optical manufacturing and support private-practice ECPs across the U.S—has been appointed to its board of directors. In making the announcement, The Vision Council said Butler will serve as a director…EYECAREMar 05 2026
Kits Eyecare Reports Record Fourth Quarter and Full Year 2025 Results VANCOUVER, British Columbia—Kits Eyecare Ltd. (TSX: KITS), a vertically integrated eyecare provider, has announced record financial results for the fourth quarter and full year ended December 31, 2025. For the full year 2025, the company advised that revenue increased 27.1 percent to a record $202.5 million, compared with $159.3 million in 2024. Gross profit increased…EYECAREMar 05 2026
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results LAKE FOREST Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses for vision correction, has announced financial results for the fourth quarter and fiscal year ended January 2, 2026. The company reported net sales of $57.8 million for the fourth quarter of 2025, up by…EYECAREMar 05 2026
Kasperek Optical Acquires Exclusive U.S. Distributorship of Luxury Italian-Made Diva Eyewear ROMULUS, Mich.—Kasperek Optical, a family-owned optical wholesale manufacturer and distributor, has announced it has entered an exclusive partnership with Ioves Spa to become the new sole U.S. distributor for its Diva Eyewear collection. The company said this collaboration brings Italian craftsmanship and luxury design directly to independent eyecare professionals across the United States. “This partnership…EYECAREMar 05 2026
Most Small Businesses Plan to Increase Marketing Budgets to Combat Inflation in 2026 WALTHAM, Mass.—While inflation and rising costs remain a top business concern for 41 percent of small business owners, the vast majority are planning to invest significantly more resources into their marketing efforts in 2026 to grow their business, according to findings from Constant Contact’s Q1 2026 Small Business Now report. The report includes a survey…EYECAREMar 04 2026
Maternal Mortality Rate in the U.S. Declines to Its Lowest Since 2018, CDC Says Maternal mortality rates in the United States have dropped to their lowest levels in recent years, according to new data published last week. The report, from the Centers for Disease Control and Prevention's National Center for Health Statistics, compared maternal deaths in 2023 and 2024, with maternal deaths defined as the death of a woman…EYECAREMar 04 2026
NYC Eyewear Design Week 2026 Kicks Off, Running March 4 to 8 NEW YORK—Eyewear Design Week, the second annual showcase for the high fashion sector of the optical market in North America, returns to New York City starting today, Wednesday, March 4 and will run through Sunday, March 8. Featured events include Loft NYC, the Kering Eyewear and Thēlios showrooms, the EYECON event, events at the Marcolin…EYECAREMar 04 2026
VSP Vision Invests $1 Million to Expand Access to Vision Care and Literacy for Children and Families RANCHO CORDOVA, Calif.—VSP Vision has announced a $1 million investment to expand access to equitable vision care and literacy resources for children and families nationwide through funding to national and local nonprofit organizations and VSP Eyes of Hope events.EYECAREMar 04 2026
National Vision Recognized Among Top Companies by Newsweek, Forbes DULUTH, Ga.—National Vision announced last week it has been named among Newsweek’s 2026 list of America’s Most Responsible Companies, and was also recognized on the Forbes’ 2026 lists for Best Companies, Dream Employers and Best Large Employers. “We are thrilled to have received each of these prestigious distinctions and to have been recognized alongside many…EYECAREMar 04 2026
ClearVision Optical Secures Workforce Training Grant to Expand Sales and Negotiation Development HAUPPAUGE, N.Y.—ClearVision Optical, a second generation family-owned, independent eyewear company, announced that it has secured a training grant through the Workforce Development Institute (WDI), a statewide nonprofit organization dedicated to helping New Yorkers build sustainable careers and thrive in a changing workforce landscape. The grant partially funded a strategic training investment for strengthening professional skills…EYECAREMar 04 2026
Eyedaptic and Venture Optical Management Form Strategic Partnership to Advance Vision Care Innovation LAGUNA HILLS, Calif.—Eyedaptic, a leader in advanced vision enhancement smart glasses and AI-powered visual assistance technology, has announced a collaborative partnership with Venture Optical Management, (VOM) a leading optical practice management organization. The collaboration aims to expand access to next-generation visual solutions and elevate patient care across VOM’s network of optical practices, the announcement stated.EYECAREMar 04 2026
Zeiss, 20/20 Magazine to Present 12 Free CE Course Descriptions During Eyewear Design Week in NYC NEW YORK—As part of the Eyewear Design Week 2026 collaboration between The Accessories Council (Ac) and Jobson Publishing, Zeiss will exclusively present a free three-day continuing education event, featuring 12 NYSSO and ABO-approved courses.EYECAREMar 04 2026
Got Elbow or Heel Pain? Shockwave Therapy Can Help Lots of studies point to a longer lifespan for people who exercise regularly. And research shows the more activity you get, the greater the potential boost in longevity. And with more than 80 million adults in the U.S. age 65 and older anticipated by mid century, the number of older, active adults is on the…EYECAREMar 03 2026
ChatGPT Health 'Under-Triaged' Half of Medical Emergencies in a New Study ChatGPT Health—OpenAI’s new health-focused chatbot—frequently underestimated the severity of medical emergencies, according to a study published last week in the journal Nature Medicine. In the study, researchers tested ChatGPT Health’s ability to triage, or assess the severity of, medical cases based on real-life scenarios.EYECAREMar 03 2026
1 in 5 Adults Developed Food Allergies After Age 18, Report Says Food allergy affects more than 33 million people in the United States—about 1 in 10 adults and 1 in 13 children—and the newly released “National Indicator Report on Food Allergy” offers insights on the growing public impact.EYECAREMar 03 2026
Zeiss Vision Care, Medical Eyeglass Center Form Strategic Partnership HEBRON, Ky.—Zeiss Vision Care, a leading global manufacturer of eyeglass lenses and ophthalmic instruments, announced today a strategic partnership with Medical Eyeglass Center (MEC), a nationally recognized, full-service optical dispensary management organization. The collaboration establishes Zeiss as the exclusive laboratory and service provider within MEC’s optical dispensary management organization and MEC as the exclusive optical…EYECAREMar 03 2026
Harrow Reports Substantial Q4 and Full-Year 2025 Revenue Growth NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a North American provider of ophthalmic disease management solutions, yesterday announced its financial results for the fourth quarter and year ended December 31, 2025. The company reported record Q4 revenue of $89.1 million, representing a 33 percent increase compared with the $66.8 million reported in the prior-year period. For the full…EYECAREMar 03 2026
Walgreens Debuts Virtual Weight Management Clinic With Access to GLP-1 MedsWalgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth subscription offerings. The retail pharmacy giant launched a digital weight management service to offer access to personalized, clinician-guided support for weight loss.EYECAREMar 02 2026
Yoga for Kids? Use of Alternative Medicine Has Grown Among Younger AmericansThe use of complementary and alternative medicine (CAM) among kids and teens in the U.S. significantly increased in recent years, a cross-sectional study showed.EYECAREMar 02 2026
Zyloware and Kenmark Appoint Scott Williams as Vice President of Sales, EastPORT CHESTER, N.Y.—Zyloware and Kenmark Eyewear have announced the appointment of Scott Williams as vice president of sales, East, effective February 23, 2026. In the newly created role, Williams will lead Eastern U.S. sales strategy and field execution, focusing on talent development, territory accountability, inventory alignment and strategic account expansion, the company advised. He joins…EYECAREMar 02 2026
Global Myopia Awareness Coalition Names 2026 Board MembersST. LOUIS—The Global Myopia Awareness Coalition (GMAC) has announced its 2026 board of directors, bringing together a distinguished group of global leaders dedicated to advancing awareness and driving global action to address the growing epidemic of childhood myopia, the organization noted. In making the announcement, the group also shared that Meredith Bishop, global medical education,…EYECAREMar 02 2026
SECO 2026: Expert Panel Discusses Treatment Options and Management Strategies for Ocular Surface DiseaseATLANTA—At a SECO 2026 special session on Friday, an expert panel discussed the latest diagnostic methods and management strategies for ocular surface disease, with a specific focus on dry eye disease, blepharitis, and meibomian gland dysfunction. The panel was moderated by Paul Karpecki, OD, Kentucky Eye Institute, and included Walt Whitley, OD, MBA, FAAO, Virginia…EYECAREMar 02 2026
AOA Foundation Announces 2026 Student Winners of the Dr. Seymour Galina Scholarship and Inaugural Silhouette ScholarshipST. LOUIS—The AOA Foundation has announced the recipients of its 2026 student scholarships, including the Dr. Seymour Galina Scholarship and the inaugural Silhouette Scholarship, which is awarded in partnership with The Silhouette Group.EYECAREMar 02 2026
Former SUNY Optometry Student and SUNY Professor Lead Strabismus Clinical Research StudyNEW YORK—SUNY College of Optometry has announced that graduate Zi Rui “Jerry” Li, OD,  and faculty collaborator Jingyun Wang, Ph.D., are advancing the development of a novel contact lens designed to treat intermittent exotropia (IXT) strabismus.EYECAREMar 02 2026
Prevent Blindness Declares March Workplace Eye Wellness Month, Shares Data from VSP Vision Care’s Workplace Vision Health ReportCHICAGO—Prevent Blindness has named March Workplace Eye Wellness Month, its annual observance offering free educational resources to employees and employers on ways to keep eyes healthy and protected in the workplace.EYECAREMar 02 2026
What Role Do Vision-Test Kiosks Have in Patient Eyecare?As artificial intelligence (AI)-enabled vision-testing kiosks continue to have a growing presence across the country in malls, universities, grocery stores and retail chains, state and national optometric organizations are sounding alarms, citing concerns over patient safety and regulation. Critics fear that consumers may mistakenly see the technology—which produces eyeglass prescriptions based on a 90-second, touch-free…EYECAREFeb 27 2026
ByHeart Infant Botulism Outbreak Ends With 48 Babies SickenedA rare outbreak of infant botulism that sickened dozens of babies who drank recalled ByHeart formula is over, with no new cases reported since mid-December, the U.S. Centers for Disease Control and Prevention said Thursday.EYECAREFeb 27 2026
‘Nearly Every’ Child With Measles Suffers This Hidden ThreatAs the U.S. measles cases soar following 2025’s record-shattering outbreaks, experts warn that health care practitioners and parents may be unprepared for the virus’s hidden threat: immune amnesia.EYECAREFeb 27 2026
Warby Parker Announces Q4 and Full Year 2025 Revenue Growth, Shares Robust 2026 GuidanceNEW YORK—Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand, yesterday announced financial results for the fourth quarter and full year ending December 31, 2025. The company reported net revenue in the fourth quarter increased $21.3 million, or 11.2 percent, to $212.0 million. For full-year 2025, net revenue increased $100.6 million, or 13.0 percent, to…EYECAREFeb 27 2026
SECO 2026 Keynote Addresses the Future of AI in EyecareATLANTA—At SECO 2026, a keynote session titled "Eye Care Reimagined: The AI Advantage" held Thursday offered a visionary look at how artificial intelligence (AI) will revolutionize clinical eyecare practice over the next 10 years.EYECAREFeb 27 2026
RxSight Reports Fourth Quarter and Fiscal Year Financial ResultsALISO VIEJO, Calif.—RxSight, Inc., (Nasdaq: RXST) an ophthalmic medical device company focused on improving vision after cataract surgery, late Wednesday announced financial results for the fourth quarter and full year ended December 31, 2025.EYECAREFeb 27 2026
EyeSouth Partners Reports Shelley Averette, COT, COE, Elected to National Board for the Certification of Ophthalmic ExecutivesATLANTA—EyeSouth Parners has announced that Shelley Averette, COT, COE, practice administrator at EyeSouth Partners affiliate Raleigh Ophthalmology, has been elected to the National Board for the Certification of Ophthalmic Executives (NBCOE).EYECAREFeb 27 2026
One in Five Blood Donors Have Elevated A1C Levels, American Red Cross FindsA report from the American Red Cross reveals that one in five blood donors have elevated A1C levels, a sign that prediabetes and diabetes are prevalent among adults in generally good health. The organization offers free A1C screening, which provided results to more than 920,000 blood donors nationwide over three testing periods in 2025. Among…EYECAREFeb 26 2026
Earth Hour 2026: Protect the Planet and Give Your Eyes a BreakNEWARK, N.J.—Earth Hour, the global movement to dim lights and give back to the planet, returns on March 28 at 8:30 p.m. your local time. Now entering its 20th year, the campaign invites individuals, communities and organizations in more than 190 countries and territories to “Give an Hour for Earth.” For 60 minutes, the campaign…EYECAREFeb 26 2026
Stanford University, Korea University and IESGA Launch Water Sustainability Index to Combat ESG GreenwashingSEOUL, South Korea—As corporate commitments to environmental, social and governance (ESG) goals reach an all-time high, a persistent blind spot remains: water. Long emphasized by professor Yong Sik Ok of Korea University, who serves as president of the International ESG Association, water stewardship has lagged behind carbon emissions, which are now tracked with near-surgical precision.…EYECAREFeb 26 2026
New Single-Pill HIV Therapy Promises Boost for Long-Term Virus SurvivorsA single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich countries cut funding to do so.EYECAREFeb 26 2026
Heart Disease and Stroke Projected to Rise Significantly in Women in the Next 25 YearsWithout better prevention and early detection, the number of women living with cardiovascular disease will increase substantially in the coming decades, the American Heart Association said Wednesday.EYECAREFeb 26 2026
Alcon Reports Strong Q4 and Full Year 2025 Financial ResultsGENEVA—Alcon (SIX/NYSE:ALC), a global leader in eyecare, has announced its financial results for the three- and twelve-month periods ending December 31, 2025. For the fourth quarter of 2025, sales were $2.7 billion, up 9 percent on a reported basis and up 7 percent on a constant currency basis, compared with the same quarter of the…EYECAREFeb 26 2026
John Luder Receives 2026 Dr. Frank D. Fontana Memorial ScholarshipRANCHO CORDOVA, Calif.—VSP Vision, in partnership with the Heart of America Eye Care Congress, announced John Luder, a fourth-year student at the University of Missouri-St. Louis (UMSL) College of Optometry, has been selected as the 2026 Dr. Frank D. Fontana Memorial Scholarship recipient. In his winning essay, Luder reflected on the principles that guide his…EYECAREFeb 26 2026
SECO 2026 Kicks Off in Atlanta, Featuring Cutting-Edge Education and InnovationATLANTA—SECO 2026, a leading source for optometric education in the U.S., attracting thousands of eyecare professionals from around the world, kicked off on Wednesday at the Georgia World Congress Center here.EYECAREFeb 26 2026
Vision Expo 2026: What’s New for the Show’s 40th Anniversary?NORWALK, Conn.—Celebrating its 40th anniversary this year, Vision Expo, produced by RX and The Vision Council, is set to take place as a single annual event from March 11 to 14, 2026, at the Orange County Convention Center in Orlando, Fla.EYECAREFeb 26 2026
Monica Van Duyne Named 2025 Fred Friedfeld Scholarship Winner by ClearVision, SUNY OptometryHAUPPAUGE, N.Y.—ClearVision Optical announced this week that it recognized the latest recipient of the Fred Friedfeld Memorial Scholarship, which is awarded in partnership with SUNY College of Optometry. The latest scholarship was presented to Monica Van Duyne.EYECAREFeb 26 2026
Why Does Women's Pain Last Longer Than Men's? A New Study Offers an AnswerScientists who study chronic pain have long puzzled over a particular type of scenario: A man and woman get into a car accident and sustain the same injuries. But the woman experiences long-lasting pain, while the man recovers more quickly.EYECAREFeb 25 2026
U.S. Child, Teen Obesity Rates Reach Record High While Adult Trends Appear to Slow, CDC Report FindsU.S. childhood and teen obesity rates have reached record-highs while adult obesity rates may be slowing, according to two new reports published early Wednesday by the Centers for Disease Control and Prevention (CDC).EYECAREFeb 25 2026
VMAIL Exclusive: EssilorLuxottica’s Uguzzoni Reflects on ‘Innovation as a Driving Force’NEWARK, N.J.—Early in 2017, Essilor and Luxottica, then 2 distinct companies, announced plans for what VMAIL reported as a “mega merger” between the two companies. Combining to form what is now known as EssilorLuxottica, (Euronext Paris: EL) it was anticipated that the deal would reshape the international optical industry, creating “an integrated player dedicated to…EYECAREFeb 25 2026
The Vision Council Responds to SCOTUS Tariff Ruling, Maps Out Potential Process for Refunds During a WebinarNEWARK, N.J.—Following the Supreme Court’s ruling last week that the President does not have the power to impose tariffs under the International Emergency Economic Powers Act (IEEPA), The Vision Council hosted a webinar yesterday updating its members and optical industry professionals on what is still unknown, how to prepare for potential new duties and offered…EYECAREFeb 25 2026
Desk Workers Spend Nearly 100 Hours a Week on Screens, Reducing Productivity, VSP Vision Care Research ShowsRANCHO CORDOVA, Calif.—VSP Vision Care has released new research revealing a concerning trend: desk workers are now getting nearly 100 hours of screen time each week, with work accounting for a substantial portion of that time.EYECAREFeb 25 2026
Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial ResultsIRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a biopharmaceutical company focused on therapeutic eyecare, announced positive financial results for the fourth quarter and full-year ending December 31, 2025, primarily driven by the successful commercial launch of its Demodex blepharitis eye drop, Xdemvy. The company reported full-year net product sales for 2025 of $451.4 million, an increase…EYECAREFeb 25 2026
U.S. Mothers Aren’t Recovering From Postpartum DepressionFor Maci Burns, a 33-year-old veterinarian and mother of two in Muncie, Indiana, the weight of new motherhood didn’t lift for years. Returning to clinic shifts just three months after her first child was born, she pumped between patients as overwhelm crept in.EYECAREFeb 24 2026
Youth Alcohol Cravings May Rise While Scrolling Social Media, Study SuggestsFor young adults, seeing alcohol-related social media content translated to greater desire to drink alcohol, especially when coming from lifestyle influencers whom they saw as highly credible, found a randomized trial.EYECAREFeb 24 2026
Alcon Appoints Kristin Anderson, OD, FAAO, Global Director of Professional Education and DevelopmentFORT WORTH, Texas—Global eyecare company Alcon has announced the appointment of Kristin Anderson, OD, FAAO, FNAP, as global director, professional education and development, with an expanded scope working across both the global vision care and ocular health franchises. In this role, she will help ensure the perspectives of eyecare professionals continue to inform pipeline and…EYECAREFeb 24 2026
Federal Court Blocks Provisions of Texas Law Focused on Managed Vision Care Plans and OD CommunicationsDALLAS—A federal judge in the U.S. District Court for the Northern District of Texas last week blocked portions of HB 1696, the 2023 Texas law that restricted how managed vision care plans communicate price and provider participation information to members. Judge James Wesley Hendrix ruled that key provisions of the statute violated the First Amendment…EYECAREFeb 24 2026
Grant Guilbert, Elevate Digital Optics CEO, Receives 2026 Vistage Impact AwardDALLAS—Elevate Digital Optics (EDO) has announced that its chief executive officer, Grant Guilbert, has been named a recipient of the 2026 Vistage Impact Award. The award is presented by Vistage, a global coaching and peer advisory organization.EYECAREFeb 24 2026
IDOC Concludes The Connection 2026, Launches New Initiatives for Membership and Independent OptometryNORWALK, Conn.—IDOC recently concluded its annual flagship conference, The Connection 2026: The Future in Focus, which brought together more than 1,000 independent optometrists, practice leaders, and industry partners for three days.EYECAREFeb 24 2026
Prevent Blindness Kicks Off Third Annual Retinopathy of Prematurity Awareness WeekCHICAGO—Prevent Blindness has declared February 23 to March 1, 2026, as its third annual Retinopathy of Prematurity (ROP) Awareness Week. The organization stated that this week is part of the comprehensive national “Prevent Blindness ROP Education and Support” initiative.EYECAREFeb 24 2026
Optical Industry Gears Up for Rock4Sight Fundraiser Concert on March 13 During Vision Expo 2026ORLANDO, Fla.—The collective of musicians and singers who perform under the Rock4Sight banner will perform at Blake Shelton’s Bar, Ole Red, on Friday, March 13, according to an announcement from organizers of the annual charity concert.EYECAREFeb 24 2026
Diabetic Retinopathy Severity Tied to Rising Dementia RiskIndividuals with type 2 diabetes—with or without retinopathy—had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with diabetes, a greater severity of diabetic retinopathy was associated with a stepwise increase in the risks for vascular and all‑cause dementia but not Alzheimer’s disease.EYECAREFeb 23 2026
U.S. Closes in on 1,000 Measles Cases in First Two Months of 2026The U.S. has officially logged 982 measles cases in 2026, the Centers for Disease Control and Prevention said Friday. It’s more than four times the number of cases as this time last year, when a large outbreak was just beginning in West Texas.EYECAREFeb 23 2026
Vision Source Launches Member Dividends Initiative to Support the Future of Private PracticeKINGWOOD, Texas—Vision Source, a North American network of independent private practice optometrists, has announced Vision Source Member Dividends, a new initiative that rewards engaged members while driving innovation, strengthening practice performance, and shaping the future of independent optometry, the organization said. According to the announcement, this initiative marks a major strategic investment in Vision Source’s…EYECAREFeb 23 2026
AOA Continues to Advocate for Student Loan Flexibility Amid Policy ChangesWASHINGTON, D.C.—In the wake of sweeping changes to federal student aid policy under the One Big Beautiful Bill Act of 2025, optometry students and schools have faced uncertainty over future access to federal loan funding, according to the American Optometric Association (AOA).EYECAREFeb 23 2026
Zeiss, 20/20 Magazine to Present 12 Free CE Course Descriptions During Eyewear Design Week in MarchNEW YORK—As part of the Eyewear Design Week 2026 collaboration between The Accessories Council (Ac) and Jobson Publishing, as reported in VMAIL in October 2025, Zeiss will exclusively present a free three-day continuing education event, featuring 12 NYSSO and ABO-approved courses. The event, which will take place March 5 through 7 at 208 W 30th Street,…EYECAREFeb 23 2026
The Vision Council Announces Publication of ANSI Z80.3-2025, Nonprescription Sunglasses, Fashion Eyewear RequirementsALEXANDRIA, Va.—The Vision Council, as the secretariat administrator for Accredited Standards Committee Z80, has announced the publication by ANSI of the 2025 revision of Standard Z80.3, Nonprescription Sunglasses and Fashion Eyewear Requirements. This revision supersedes the 2018 Standard and represents over five years of work by a team of industry experts, led by chair Dr.…EYECAREFeb 23 2026
U.S. Supreme Court Rules President Cannot Impose Tariffs Under IEEPANEWARK, N.J.—In a highly anticipated decision, the Supreme Court of the United States (SCOTUS) issued an opinion today in the case of Learning Resources, Inc. v. Trump, holding that the President does not have the power to impose tariffs under the International Emergency Economic Powers Act (IEEPA). The 170-page opinion ruling reveals a vote of…EYECAREFeb 20 2026
Seeing Gold: What the Olympics Can Teach Us About Sports VisionThe Winter Olympics present a visual environment that is uniquely unforgiving: high contrast white slopes, bright UV rays reflected from snow and ice, and rapid temperature changes that turn lenses into fogging hazards. These conditions make clear that performance vision at the games is as much about managing environment and equipment as it is about…EYECAREFeb 20 2026
Using Saliva to Detect Disease Holds Promise, but It's Not Perfected YetThe saliva circulating in your mouth contains troves of microbial information about the rest of your body and is easier to collect than blood samples. Today, a few drops of spit can help detect viruses like HIV and the one that causes COVID-19, or assess genetic risks for breast cancer.EYECAREFeb 20 2026
Top Business and Health Care Experts to Explore the Power of ‘Resilience Rising’ at VM SummitNEWARK, N.J.—Vision Monday’s 2026 Leadership Summit titled, “Resilience Rising: Future-Proofing Your Business for the 21st Century,” will analyze what resilience means to today’s eyecare leaders and will offer attendees the opportunity to learn which big ideas and trends are slated to make an impact on their businesses, practices and the optical industry. The VM summit,…EYECAREFeb 20 2026
Tarsus Pharmaceuticals Appoints David Pyott to its Board of DirectorsIRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced the appointment of David E. I. Pyott, a leader in the global biopharmaceutical industry and former chairman and CEO of Allergan, Inc., to its board of directors, effective immediately. Pyott brings decades of global…EYECAREFeb 20 2026
Carl Zeiss Meditec Reports First-Quarter Results, Cites ‘Weak Start’ to Fiscal Year 2025/26JENA, Germany—Carl Zeiss Meditec has announced its first-quarter fiscal 2025/26 financial results, reporting revenue of €467 million for the first quarter, down 4.8 percent year-over-year, as compared with €490.5 million for the same period the prior year. EBITA amounted to €8.1 million, compared with €35.2 million the prior year, with the EBITA margin coming in…EYECAREFeb 20 2026
WestGroupe and Waterloo Eye Institute Celebrate Third Year of Partnership in Advancing Canadian EyecareMONTREAL, Quebec and WATERLOO, Ontario—WestGroupe and Waterloo Eye Institute (WEI) are celebrating the third year of their collaboration focused on advancing Canadian eyecare, the two organizations announced this week.EYECAREFeb 20 2026
GoodVision USA Launches the GoodVision Alliance, Connecting Optical Practices to Global Vision CareNEWTON, Mass.—GoodVision USA has announced the launch of the GoodVision Alliance: a cause-marketing program that allows independent eyecare practices to fund global vision care while differentiating their business in a market that gets more competitive every year.EYECAREFeb 20 2026
Silmo Academy Bali Is Set for April 6-8, 2026BALI, Indonesia—The renowned Silmo Academy is expanding its commitment to excellence, education, and knowledge sharing for vision care and optical professionals by holding the Silmo Academy Bali, a conference from April 6 to 8, 2026, at the Paradisus by Meliá Bali hotel in Indonesia.EYECAREFeb 20 2026
Heading Back to School Can Improve Happiness in Seniors, Study RevealsLifelong learning may be the key to overall happiness and good health. A new survey from the University of San Francisco's Fromm Institute for Lifelong Learning reveals that 82 percent of adults aged 50 and over who returned to the classroom reported improved life satisfaction. Participants also cited expanded social networks, improved mental health and…EYECAREFeb 19 2026
Some People Get ‘Stuck’ in Grief—Now Scientists Think They Know WhyFor most people, the pain of losing a loved one gradually lessens over time. But for others, however, that healing never comes. Instead, grief stays raw, consuming and unrelenting—a condition known as prolonged grief disorder (PGD).EYECAREFeb 19 2026
Kids With Sleep Apnea May Face Higher Risks of Flu, COVIDChildren and adolescents with obstructive sleep apnea (OSA) were twice as likely to be diagnosed as having influenza or COVID-19 in the five years following diagnosis than those without the condition, according to a large study published in the Journal of Clinical Sleep Medicine.EYECAREFeb 19 2026
Cancer and HIV Vaccines Enter the Therapeutic EraFor decades, vaccination has been strongly associated with the prevention and priming of the immune system to protect against future infections. Although this principle still holds, the concept has expanded in recent years. Vaccines are now being developed not only to prevent disease but also as therapeutic tools designed to retrain the immune system to…EYECAREFeb 19 2026
Bausch + Lomb, ‘Harnessing Momentum,’ Reports Fourth Quarter and Full-Year Revenue GrowthVAUGHAN, Ontario—Eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced on Wednesday its fourth-quarter and full-year 2025 financial results and also provided 2026 guidance. The company reported revenue growth across all business segments in both the fourth quarter and for the full-year, including increases in vision care, surgical and pharmaceutical. During the fourth quarter,…EYECAREFeb 19 2026
FDA Approves Expanded Age Range for STAAR Surgical’s EVO ICL for Vision CorrectionLAKE FOREST, Calif.—STAAR Surgical Company, a leading developer of phakic intraocular lenses with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded age indication for EVO/EVO+ Visian ICL for patients aged 21 to 60 years old, up from…EYECAREFeb 19 2026
Outlook Therapeutics Reports Q1 Fiscal Year 2026 Financial ResultsISELIN, N.J.—Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on improving the standard of care for bevacizumab in treating retina diseases, has announced its financial results for the first quarter of fiscal year 2026, which concluded on December 31, 2025.EYECAREFeb 19 2026
Women In Optometry Adds Seven New Advisory Board MembersNEW YORK—Women In Optometry (WO) announced it has welcomed seven new professional advisory board members to serve from 2026 to 2028. The WO professional advisory board plays a critical role in guiding editorial direction for the platform and alerting editors to important topics and issues.EYECAREFeb 19 2026
U.S. Small Business Administration Announces 2025 Boots to Business Instructor of the Year Award WinnersWASHINGTON, D.C.—The U.S. Small Business Administration (SBA) has announced the winners of the 2025 Boots to Business Instructor of the Year awards, honoring educators and professionals whose service and dedication have made a lasting difference for America’s service members, veterans, and military spouses pursuing entrepreneurship. The Boots to Business (B2B) program provides foundational entrepreneurship courses…EYECAREFeb 18 2026
At What Age Should You Be Screened for Colorectal Cancer?The recent death of the 48-year-old actor James Van Der Beek is again highlighting how colorectal cancer is increasingly killing younger people. Overall, cancer death rates in people younger than 50 have dropped by 44 percent since 1990. But after increasing for decades, colorectal cancer is now the leading cause of cancer death in people…EYECAREFeb 18 2026
Caught the Stomach Bug? Here’s How to Tell If It’s NorovirusNorovirus, which is most often spread through contaminated food or water, has been making its rounds again during the winter season. While the symptoms can hit hard and fast, the small silver lining is that the illness is usually short-lived, clearing the system within one to three days.EYECAREFeb 18 2026
Alzheimer's Sex Gap: Similar Biomarkers, but Faster Decline for WomenWomen had worse outcomes than men at similar levels of Alzheimer's disease pathology, data from a multi-cohort analysis suggested. When amyloid-beta was present, women had higher baseline phosphorylated tau 217 (p-tau217) levels compared with men (β = -0.21, 95 percent CI -0.37 to -0.05, P=0.009) in three of five cohorts, reported Gillian Coughlan, PhD, MSc,…EYECAREFeb 18 2026
Glaukos Reports Fourth Quarter and Full Year 2025 Financial ResultsALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, has announced its fourth quarter and full year 2025 financial results. Net sales in the fourth quarter of 2025 climbed to $143.1 million, a 36 percent increase (34…EYECAREFeb 18 2026
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary SharesLONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company, has announced the pricing of an underwritten public offering of 10,815,000 ordinary shares at an offering price of $1.85 per ordinary share.EYECAREFeb 18 2026
Opus Genetics Enters Agreement for $25 Million Private PlacementRESEARCH TRIANGLE PARK, N.C.—Opus Genetics, Inc. (Nasdaq: IRD) announced that it has entered into a securities purchase agreement (SPA) for a private placement of 7,374,632 shares of its Series B non-voting convertible preferred stock at a price of $3.39 per share.EYECAREFeb 18 2026
20/20 and Ac Magazine Debut Guide to Eyewear Design Week, Available Now OnlineNEW YORK—Jobson Publishing, publisher of Vision Monday and 20/20 magazine, and the Accessories Council (Ac), publisher of Ac Magazine, are proud to announce the debut of their guide to Eyewear Design Week, part of a collaboration between the two organizations first reported in VMAIL in October 2025. The collaboration, which includes the digital magazine, is…EYECAREFeb 17 2026
Heart Issues During Pregnancy Could Set the Stage for Future Stroke, Heart Attack RiskAs American Heart Month gets underway, experts are warning that heart issues during pregnancy could set the stage for future risks from stroke and heart attack. Cardiovascular disease during pregnancy is the leading cause of pregnancy-related death in the United States, according to the American College of Obstetricians and Gynecologists (ACOG).EYECAREFeb 17 2026
Diabetes Remission Is Possible, but There’s Not Just One WayCurrent research supports the idea that remission of type 2 diabetes is increasingly achievable. A 2023 study published in Diabetes Care showed that an intensive low-energy total diet replacement program in Australian primary care led to diabetes remission at 1 year in about half of the participants with recently diagnosed type 2 diabetes, with higher…EYECAREFeb 17 2026
Sandra S. Block, OD, to Deliver Keynote Address at Most Influential Women in Optical LuncheonNEWARK, N.J.—Vision Monday is pleased to announce that the keynote address for the 2026 Most Influential Women in Optical (MIWO) luncheon will be delivered by Sandra S. Block, OD, DOS, (h.c), M. Ed., MPH, FAAO, Dipl AAO, FOVDRA, DAAO, FNAP, FARVO, professor emeritus at Illinois College of Optometry (ICO). This year’s special luncheon event and…EYECAREFeb 17 2026
2026 MIPS Criteria, Determining Reimbursement Rates for Medicare Patients, Will Maintain Current Standards for ODsWASHINGTON, D.C.—For the 2026 reporting year, the Merit-based Incentive Payment System (MIPS), which determines reimbursement rates for traditional Medicare patients, will stay largely the same for optometrists, according to an announcement from the American Optometric Association (AOA). This news comes as the Centers for Medicare and Medicaid Services (CMS) year is starting, said Rebecca Wartman,…EYECAREFeb 17 2026
Two Blind Brothers Achieves 501c3 Nonprofit Charity StatusNEW YORK—Two Blind Brothers, the mission-driven organization founded by brothers Bradford and Bryan Manning, announced it has officially been recognized as a 501(c)(3) nonprofit charity, marking a major milestone in its journey to support the blind and visually impaired community.EYECAREFeb 17 2026
EssilorLuxottica Board of Directors to Propose Reappointment of 8 Directors; Group Launches Share Buyback PlanPARIS—The EssilorLuxottica (Reuters: ESLX.PA) board of directors announced it intends to propose the reappointment of the eight directors whose terms are expiring at the shareholders’ meeting set for April 28, 2026.EYECAREFeb 17 2026
New Research Helps Build Understanding of Genetic Risks and Treatment Options for AMD and Low VisionAn aging population is driving a steady rise in reported cases of age-related macular degeneration (AMD), and with AMD and Low Vision Awareness Month underway this month, education and advocacy are top of mind for eyecare professionals (ECPs) who treat patients with this condition. According to research from the journal Cureus, an estimated 20 million…EYECAREFeb 13 2026
Common Drug Could Stop Alzheimer’s Process ‘Before It Even Begins’A medication that has been prescribed in the U.S. for decades may be able to stop the earliest steps of Alzheimer’s disease—but only if it is taken long before symptoms appear, according to new research from Northwestern University.EYECAREFeb 13 2026
Fielmann Group’s Preliminary 2025 Financial Results Show Growth as Company Concludes Vision 2025 InitiativeHAMBURG, Germany—The Fielmann Group (ETR: FIE), a leading global eyewear provider, announced preliminary, unaudited results for the financial year 2025 that demonstrated overall growth. In making the announcement, the company reported generating total consolidated sales of €2,435 million, a 7.4 percent increase compared with the previous year of €2,267 million. According to the company, half…EYECAREFeb 13 2026
CooperVision Inducted Into Nova Southeastern University Fellows SocietyROCHESTER, N.Y.—CooperVision announced that it has been inducted into the Nova Southeastern University (NSU) Fellows Society, the university’s premier recognition group honoring leaders whose cumulative giving exceeds $100,000 in support of the university.EYECAREFeb 13 2026
Americans Are Worried About Catching the Flu, Bradley Company ReportsAmericans are growing significantly more concerned about getting sick, according to the 2026 Healthy Handwashing Survey by Bradley Company, a commercial washroom and industrial safety company. 70 percent of Americans are very or somewhat concerned about contracting the flu compared to 59 percent who felt that way just three years ago.The survey reveals that 81…EYECAREFeb 12 2026
AI in Eye Care: AI and the Acceleration of Drug DevelopmentLike it or not, artificial intelligence has likely impacted your daily life in some way. Whether you use ChatGPT to organize your day or have begun to integrate AI-driven tools in a clinical setting, it is clear that the era of AI in medicine has arrived. One potential revolutionary impact could be the use of…EYECAREFeb 12 2026
Top 10 Countries and Regions for LEED Ranking Outside the U.S. Are AnnouncedWASHINGTON—The U.S. Green Building Council (USGBC), the global developer of the LEED (Leadership in Energy and Environmental Design) rating system, and Green Business Certification Inc. (GBCI), the organization independently recognizing excellence in green business industry performance and practices globally, has announced the annual Top 10 countries and regions for LEED ranking outside the United States…EYECAREFeb 12 2026
Colon Cancer Is Now the Deadliest Cancer for Young AdultsJenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent discomfort. She was told it was normal, that the aches “came with the territory,” she said.EYECAREFeb 12 2026
The Scary Health Risk That Can Sneak Up on GLP-1 UsersJennifer Lynn-Pullman had been taking Wegovy for a few months when she began shivering during a walk on a hot August day. "It was about 85 degrees–I should have been sweating," said Lynn-Pullman, a 48-year-old dietitian from Pennsylvania.EYECAREFeb 12 2026
EssilorLuxottica Reports Strong Q4 and 2025 Revenue Growth, Nods to Myopia Management PortfolioPARIS—EssilorLuxottica (Reuters: ESLX.PA) on Wednesday reported 2025 full-year financial results, with consolidated revenue reaching €28,491 million, a year-over-year increase of 11.2 percent at constant exchange rates, compared with full-year 2024. In the fourth quarter of 2025, the company reported consolidated revenue of €7,600 million, up 18.4 percent at constant exchange rates compared with the same…EYECAREFeb 12 2026
Hoya Vision Care Announces Leadership Changes to Advance North American Commercial, Operational AlignmentLEWISVILLE, Texas—Hoya Vision Care, a global leader in ophthalmic lens technology, has announced North American leadership changes designed to strengthen its commercial and operational capabilities. Steven Haifawi, who currently serves as president of Hoya Vision Care Canada, will step into the role of senior vice president, U.S. Commercial, leading the company’s newly unified ECP sales,…EYECAREFeb 12 2026
Cira Collins, Victoria Hallberg and Kristen Tischler Join Lineup of Presenters at Most Influential Women in Optical LuncheonNEWARK, N.J.—Vision Monday is pleased to announce Cira Collins, optical coordinator for Kaiser Permanente, Victoria Hallberg, senior vice president of sales for Zyloware and Kenmark Eyewear, and Kristen Tischler, chief marketing officer at Advancing Eyecare, have joined the lineup of presenters for the 2026 Most Influential Women in Optical (MIWO) luncheon. This year’s special luncheon…EYECAREFeb 12 2026
OKYO Pharma Appoints Flavio Mantelli, MD, as Chief Medical OfficerLONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company, has announced the appointment of Flavio Mantelli, MD, Ph.D., as chief medical officer, effective immediately.EYECAREFeb 12 2026
Stanton Optical Opens First Four ‘Store-in-Store’ Locations Inside Staples StoresFRAMINGHAM, Mass. and DELRAY BEACH, Fla.—Now Optics, parent company of Stanton Optical, and Staples have announced the grand opening of the first four “store-in-store” Stanton Optical locations inside select Staples stores in the Philadelphia area.EYECAREFeb 12 2026
U.S. Small Business Employment Trends Hold Steady at Start of 2026, Paychex SaysROCHESTER, N.Y.—U.S. small businesses started 2026 with steady trends in job and wage growth, according to the January Paychex Small Business Employment Watch. The Small Business Jobs Index, which tracks payroll data for a subset of Paychex clients with fewer than 50 employees, slightly increased by 0.04 percentage points to 99.30 in January. Furthermore, the…EYECAREFeb 11 2026
Over 70 Percent of Tested Baby Foods Are Ultraprocessed and Full of AdditivesThe vast majority of baby foods, drinks and snacks sold in the United States for children ages 6 months to 36 months are ultraprocessed and may contain additives increasingly linked to potential health harms, a new study found.EYECAREFeb 11 2026
What to Know About a New Study on Coffee, Tea, Caffeine and Dementia RiskA long-term analysis shows that people who drink caffeinated coffee and tea have a lower risk of developing dementia, although the study does not prove cause and effect. Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, warned that the results should be taken "with a massive grain…EYECAREFeb 11 2026
Metabolic Syndrome Tied to Glaucoma RiskAdults aged 40 years or older with metabolic syndrome were more likely to have glaucoma than their peers, whereas those with higher BMI or larger waist circumference were less likely to have this eye condition.EYECAREFeb 11 2026
NBEO Shares Continued Concerns Over Optometric Licensing Measures in Kentucky, Citing ‘Gaps in Public Protection’NEWARK, N.J.—Controversy continues within the Kentucky optometric community following ongoing concerns after 21 optometrists in the state received licenses between 2020-2023 without passing all required parts of the National Board of Examiners in Optometry (NBEO) three-part exam. The dispute has its roots in pandemic-era adjustments the Kentucky Board of Optometric Examiners (KBOE) made to reduce…EYECAREFeb 11 2026
Kering Eyewear Reports Revenue for Fourth Quarter and Full-Year 2025PARIS—Kering Eyewear, part of the global luxury group Kering (KER.PA), reported 2025 full-year revenue growth of 1 percent compared with the same period in 2024. During the group's earnings call yesterday, the company said overall revenue from the Kering Eyewear and corporate segment amounted to €1.6 billion, up 3 percent on a comparable basis for…EYECAREFeb 11 2026
World Council of Optometry Appoints Two New Trustees to Its Charitable FoundationST. LOUIS—The World Council of Optometry (WCO) and World Optometry Foundation (WOF), WCO’s charitable arm dedicated to advancing global eye health and reducing avoidable blindness, have announced the appointment of Dr. Juan Carlos Aragón (Costa Rica) and Dr. Scott Mundle (Canada) to the WOF’s board of trustees. According to the announcement, Dr. Aragón and Dr.…EYECAREFeb 11 2026
Bridging Eye Disease Care With Addiction ServicesEric Gaier, MD, PhD, and Dean Eliott, MD, of the Department of Ophthalmology at Mass Eye and Ear, a member of the Mass General Brigham health care system, are co-authors of a paper published in Ophthalmology Retina, “Substance Use Disorder Interventions and Ophthalmic Outcomes for Injection Drug Use-Associated Endogenous Endophthalmitis.”EYECAREFeb 10 2026
Long COVID May Be Triggering Alzheimer’s-Like Changes in the Brain: New StudyThe effects of long COVID rage on. Over 20 million Americans are believed to have the debilitating post-infection condition, suffering symptoms such as severe fatigue, shortness of breath, chest pain, palpitations, dizziness and muscle pain.EYECAREFeb 10 2026
EssilorLuxottica Unveils Agenda for 3-Day SWITCH EventNEWARK, N.J.—EssilorLuxottica’s 3-day event titled “SWITCH: Vision Innovation Summit by EssilorLuxottica,” will be held March 9-11, 2026, in Orlando, Fla., and is designed to give ECPs a first look at the future of vision care.EYECAREFeb 10 2026
Stanton Optical Opens New Location in Royal Palm Beach, Fla.ROYAL PALM BEACH, Fla.—Stanton Optical, a leading retail brand under Now Optics, has announced the opening of its newest location in Royal Palm Beach, Fla. The opening marks Stanton Optical’s 45th location in Florida and 12th location in the West Palm Beach area.EYECAREFeb 10 2026
Review of Ophthalmology: Patient Selection Pearls for Presbyopia Drops“It’s 10 p.m., do you know where your reading glasses are?” For those with presbyopia, daily life can feel a little like that old public service commercial reminding parents to make sure their kids were home before curfew. Surgical correction methods are available, but not every patient is eligible, nor are they always interested in…EYECAREFeb 09 2026
Vision Monday Posts Its First-Ever Digital-Only Edition With January-February Double IssueNEWARK, N.J.—Vision Monday and Jobson Optical Group are proud to announce the release of their first-ever digital-only edition, now available here online. With this new approach that leans heavily into digital interactivity and video formats, VM brings readers even closer to today’s newsmakers, giving access to intimate, one-on-one conversations, exclusive interviews with key thought leaders,…EYECAREFeb 09 2026
Four Times as Many Measles Cases in a Few Weeks Than U.S. Typically Averages in a Whole Year: CDCThere have been at least 733 confirmed measles cases reported across the nation, the latest data from the Centers for Disease Control and Prevention showed Friday. In just a few weeks, the United States reported four times as many cases than typically seen throughout an entire calendar year, the CDC said.EYECAREFeb 09 2026
Risk-Based Breast Cancer Screening Nears a Turning PointThe case for replacing age-based breast cancer screening with personalized risk-based screening is gaining strength— with recent studies showing the approach is feasible and has the potential to save more lives.EYECAREFeb 09 2026
Erika Jurrens, Michelle Skinner to Present at VM’s 2026 Most Influential Women in Optical LuncheonNEW YORK—Vision Monday is pleased to announce the first featured presenters for the 2026 Most Influential Women in Optical (MIWO) luncheon include Erika Jurrens, senior vice president of ECP growth channels at EssilorLuxottica, and Michelle Skinner, chief provider solutions officer at VSP Vision. The special luncheon event and program to pay tribute to this year’s…EYECAREFeb 09 2026
Hoya Vision Care’s MiYOSMART iQ Lenses Show No Myopia Progression on Average at Six Months, Clinical Trial ShowsHONG KONG—Hoya Vision Care officially presented interim 6-month clinical evidence from a randomized controlled clinical trial evaluating the safety and efficacy of MiYOSMART iQ spectacle lenses in children aged 4-12 with progressive myopia at the 41st Asia-Pacific Academy of Ophthalmology Congress held here on February 6, the company announced. MiYOSMART iQ spectacle lenses are Hoya…EYECAREFeb 09 2026
American Optometric Association’s 2025 Advocacy Efforts Set the Stage for 2026, Group SaysST. LOUIS—The American Optometric Association (AOA) announced that it achieved several significant federal and state advocacy achievements for doctors and patients in 2025, including securing a 2.5 percent increase in Medicare physician reimbursement for 2026.EYECAREFeb 09 2026
SpyGlass Pharma Raises $150 Million in Initial Public OfferingALISO VIEJO, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company focused on intraocular lens and drug delivery solutions for chronic eye conditions such as glaucoma, announced it raised $150 million in its initial public offering (IPO).EYECAREFeb 09 2026
Johnson & Johnson Named Inaugural Global Impact Award Winner by the Healthcare Businesswomen's AssociationFAIRFIELD, N.J.—Johnson & Johnson (NYSE: JNJ) has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen's Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the health care and life sciences industries.EYECAREFeb 09 2026
Patient Non-Adherence in the Optometric Setting: ODs Discuss Impact and SolutionsPatient non-adherence—which includes not following treatment plans, missing appointments, or failing to take medications as prescribed—is a complex issue which spans the health care spectrum, compromises patient safety and places a financial burden on health care systems. Non-adherence can be broadly separated into two categories: intentional (a conscious decision by the patient) or unintentional (caused…EYECAREFeb 06 2026
A New Study on Statins Reveals Surprise About Popular DrugsThe long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side effects are really a risk.EYECAREFeb 06 2026
Mediterranean Diet Can Reduce Risk of Stroke by up to 25 Percent, Long-Term Study SuggestsA Mediterranean diet can reduce the risk of every type of stroke, in some cases by as much as 25 percent, a large study conducted over two decades suggests.EYECAREFeb 06 2026
VIEW Optometry Launches Doctor-Led Alliance to Strengthen Independent EyecareBRENHAM, Texas—VIEW Optometry, a new doctor-led alliance dedicated to supporting private practice optometrists and protecting their independence, officially announced its launch yesterday. Founded by Tommy Lucas, OD, and Mary Kate Walters, OD, FAAO, the group aims to preserve and grow the private practice market segment, improve profitability and lessen financial pressures on optometry practices, and…EYECAREFeb 06 2026
Pearle Vision Celebrates 65th Anniversary, Reflects on Latest Year of Growth and InnovationNEW YORK—Pearle Vision, a leading national eyecare franchise, announced it is celebrating a landmark achievement in 2026 with the 65th anniversary of its founding by Dr. Stanley Pearle. This anniversary milestone underscores the brand’s lasting commitment to genuine eyecare, clinical excellence and community-based service, the company said in the announcement—values that have fueled Pearle’s growth…EYECAREFeb 06 2026
SECO International Reveals 2026 Awards of Excellence WinnersATLANTA—SECO International has announced the recipients of the 2026 SECO Awards of Excellence, recognizing extraordinary individuals and organizations whose dedication strengthens patient care, advances professional education, and elevates optometry across the South and beyond.EYECAREFeb 06 2026
Ocular Therapeutix Reports Fourth Quarter and Full Year 2025 Financials, Provides Business HighlightsBEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, has reported financial results for the fourth quarter and year ended December 31, 2025, and provided recent business highlights.EYECAREFeb 06 2026
Clinique Joins Forces With Acuvue on Visionary Collaboration to Advance Eye Education in Beauty and VisionNEW YORK—Clinique has announced a visionary collaboration in the U.S. with Acuvue, a leading contact lens brand from Johnson & Johnson Vision, to advance eye education in beauty and vision by informing consumers that they can wear contacts and eye makeup confidently.EYECAREFeb 06 2026
Canadian Ophthalmological Society Highlights Advances in AMD Care During Awareness MonthThe Canadian Ophthalmological Society (COS) is marking Age-Related Macular Degeneration (AMD) Awareness Month by drawing attention to recent advances in care, the varied ways the disease affects patients, and the broader personal and societal impact of vision loss across Canada.EYECAREFeb 05 2026
Pink Noise May Be Bad for Sleep Quality, New Research FindsPink noise, a staticky sound that’s supposed to help people fall asleep, may actually worsen your rest, a new study found. Pink noise—like white noise—contains all the frequencies humans can hear, but it plays lower frequencies more prominently.EYECAREFeb 05 2026
Heart Attack, Stroke Risk Rises After Serious RSV, Study SaysAdults hospitalized with an acute respiratory syncytial virus (RSV) infection may face a sharp risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a retrospective self-controlled case study.EYECAREFeb 05 2026
Optical Women’s Association Expands Globally, Spotlights Courage and Authenticity in Leadership at MidoMILAN, Italy—The Optical Women’s Association (OWA) announced that it successfully hosted its OWA Global Connection Event at Mido in Milan, marking an important milestone in the organization’s continued international expansion and its mission to empower women in leadership roles across the global optical industry. OWA said the event, titled “Leading with Courage: Inspiring Stories of…EYECAREFeb 05 2026
Vision Expo and VSP Vision Name Finalists for 2026 VSP Vision Innovation ChallengeNORWALK, Conn. and RANCHO CORDOVA, Calif.—Vision Expo, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, announced the four startups that will participate in the 2026 VSP Vision Innovation Challenge.EYECAREFeb 05 2026
Pacific University’s Patrick Caroline Receives National Award For Specialty Contact Lens AdvocacyFOREST GROVE, Ore.—Pacific University has announced that associate professor of optometry Patrick Caroline has been honored for his longtime research and advocacy in the field of medically necessary specialty contact lenses.EYECAREFeb 05 2026
Vallon Expands North American Sales Team to Accelerate Retail Growth in Key MarketsAMSTERDAM—Vallon, an independently-owned outdoor eyewear brand, announced that it is expanding its North American presence with a dedicated six-person sales team, now covering key regions across the United States and Canada.EYECAREFeb 05 2026
Scientists Warn Against Breathing in Secondhand Vape ‘Smoke’Breathing in lingering, secondhand e-cigarette vapors has the potential to damage lung tissues. This is the warning of a new study by researchers from the University of California Riverside, who found that aged vape aerosols contain fine particles bearing metals and highly reactive compounds that can combine to produce harmful radical particles.EYECAREFeb 04 2026
When the Doctor Needs a CheckupHe was a surgical oncologist at a hospital in a Southern city, a 78-year-old whose colleagues had begun noticing troubling behavior in the operating room. During procedures, he seemed “hesitant, not sure of how to go on to the next step without being prompted” by assistants, said Mark Katlic, director of the Aging Surgeon Program…EYECAREFeb 04 2026
New Wearable Patch Detects Skin Cancer: How It WorksMore than 8,500 people are expected to die from melanoma in the U.S. in 2026. Early detection dramatically improves survival, yet the tools for identifying suspicious lesions remain, well, cumbersome.EYECAREFeb 04 2026
PECAA Expands Business Advisory Services to Meet Demand for Customized Private Practice GuidanceBOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) announced that it is expanding its Business Advisory services due to higher member demand for customized private practice guidance and operational efficiency.EYECAREFeb 04 2026
Foundation Fighting Blindness Names Two Blind Brothers as Presenting Sponsor, Reveals Its Visionary Award Honorees for Night for Sight GalaCOLUMBIA, Md.—The Foundation Fighting Blindness, a private funding source for research on retinal degenerative diseases, announced that it will host its annual Night for Sight gala on May 14, 2026, at Guastavino's in New York City.EYECAREFeb 04 2026
Orbis International Appoints Ann Wang as Chief of StaffNEW YORK—Orbis International announced that it has appointed Ann Wang as its new chief of staff, a newly created position in the organization. As a key member of the executive leadership team, Wang will serve as the principal advisor to the president and CEO.EYECAREFeb 04 2026
Large-scale study of ocular biometry in Korean adults: age-related trends and associations Eye, Published online: 04 March 2026; doi:10.1038/s41433-026-04377-5Large-scale study of ocular biometry in Korean adults: age-related trends and associationsEyeMar 04 2026
Facing dynamic changes in the era of pickleball ocular injuries Eye, Published online: 04 March 2026; doi:10.1038/s41433-026-04386-4Facing dynamic changes in the era of pickleball ocular injuriesEyeMar 04 2026
Large language model-based scribing tools for ophthalmology: performance and safety evaluation using simulated clinical encounters Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04325-3Large language model-based scribing tools for ophthalmology: performance and safety evaluation using simulated clinical encountersEyeMar 03 2026
Clinical characteristics and treatment outcome of conjunctival myxoma Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04316-4Clinical characteristics and treatment outcome of conjunctival myxomaEyeMar 03 2026
Research design concerns in a retrospective cohort study of retinal disease and visual impairment in individuals with psychiatric disorders Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04339-xResearch design concerns in a retrospective cohort study of retinal disease and visual impairment in individuals with psychiatric disordersEyeMar 03 2026
Corneo-scleral necrosis following diode laser cyclophotocoagulation Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04367-7Corneo-scleral necrosis following diode laser cyclophotocoagulationEyeMar 03 2026
Response to: ‘Comment on ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study” Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04379-3Response to: ‘Comment on ‘Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study”EyeMar 03 2026
Evaluation of photoreceptor integrity in diabetic retinopathy using high-resolution optical coherence tomography Eye, Published online: 03 March 2026; doi:10.1038/s41433-026-04353-zEvaluation of photoreceptor integrity in diabetic retinopathy using high-resolution optical coherence tomographyEyeMar 03 2026
Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemicEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04344-0Predictive factors for visual acuity in diabetic macular oedema: lessons for clinical practice learned from deferring intravitreal injections under the COVID-19 pandemicEyeMar 02 2026
Correction: Management and outcomes of ocular surface squamous neoplasia at a tertiary hospital, South AfricaEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04313-7Correction: Management and outcomes of ocular surface squamous neoplasia at a tertiary hospital, South AfricaEyeMar 02 2026
<b>A</b>flibercept 2 mg Biosimilar (aflibercept-ayyh<b>, P</b>avblu): <b>Ex</b>perience of safety in clinical settings-<b>APEX- safety study</b>Eye, Published online: 02 March 2026; doi:10.1038/s41433-026-04327-1Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety studyEyeMar 02 2026
Late-onset choroidal detachment after combined surgery for glaucoma and cataractEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04376-6Late-onset choroidal detachment after combined surgery for glaucoma and cataractEyeMar 02 2026
Hermansky-Pudlak SyndromeEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04388-2Hermansky-Pudlak SyndromeEyeMar 02 2026
Multimodal imaging in nanophthalmosEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04354-yMultimodal imaging in nanophthalmosEyeMar 02 2026
Morphological mimicry—lens deposits resemble cocciEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04349-9Morphological mimicry—lens deposits resemble cocciEyeMar 02 2026
The vanishing golden fundus: visualizing the Mizuo–Nakamura phenomenon in GRK1-associated Oguchi disease in a childEye, Published online: 02 March 2026; doi:10.1038/s41433-026-04389-1The vanishing golden fundus: visualizing the Mizuo–Nakamura phenomenon in GRK1-associated Oguchi disease in a childEyeMar 02 2026
The global clinical trial landscape for glaucoma over the past three decades: current status and future prospectsEye, Published online: 28 February 2026; doi:10.1038/s41433-026-04384-6The global clinical trial landscape for glaucoma over the past three decades: current status and future prospectsEyeFeb 28 2026
Performance of modern large language models in ophthalmic knowledge assessment: a comparative assessment of OpenEvidence, ChatGPT-5.1, and Gemini 3.0 ProEye, Published online: 27 February 2026; doi:10.1038/s41433-026-04373-9Performance of modern large language models in ophthalmic knowledge assessment: a comparative assessment of OpenEvidence, ChatGPT-5.1, and Gemini 3.0 ProEyeFeb 27 2026
Incidence of post-traumatic endophthalmitis following repaired open globe injury: impact of prophylactic intracameral moxifloxacinEye, Published online: 26 February 2026; doi:10.1038/s41433-026-04338-yIncidence of post-traumatic endophthalmitis following repaired open globe injury: impact of prophylactic intracameral moxifloxacinEyeFeb 26 2026
10-year analysis of microbiological profiles and in vitro antimicrobial susceptibility: the Kent microbial keratitis studyEye, Published online: 26 February 2026; doi:10.1038/s41433-026-04302-w10-year analysis of microbiological profiles and in vitro antimicrobial susceptibility: the Kent microbial keratitis studyEyeFeb 26 2026
Response to: Comment on: “Epiretinal membrane formation and incomplete separation of the posterior hyaloid membrane”Eye, Published online: 26 February 2026; doi:10.1038/s41433-026-04364-wResponse to: Comment on: “Epiretinal membrane formation and incomplete separation of the posterior hyaloid membrane”EyeFeb 26 2026
Comment on: ‘Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation’Eye, Published online: 26 February 2026; doi:10.1038/s41433-026-04350-2Comment on: ‘Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation’EyeFeb 26 2026
Clinical significance of serum IgE levels in IgG4-related ophthalmic disease: a single-centre studyEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04342-2Clinical significance of serum IgE levels in IgG4-related ophthalmic disease: a single-centre studyEyeFeb 25 2026
Comment on: ‘Epiretinal membrane formation and incomplete separation of the posterior hyaloid membrane’Eye, Published online: 25 February 2026; doi:10.1038/s41433-026-04362-yComment on: ‘Epiretinal membrane formation and incomplete separation of the posterior hyaloid membrane’EyeFeb 25 2026
Cornea as a window to the angle: striking anterior segment photography in neglected congenital glaucomaEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04357-9Cornea as a window to the angle: striking anterior segment photography in neglected congenital glaucomaEyeFeb 25 2026
Minimum reporting elements for ophthalmic vision–language model studiesEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04366-8Minimum reporting elements for ophthalmic vision–language model studiesEyeFeb 25 2026
Retinal venous malformation associated with ipsilateral cerebral venous malformationEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04337-zRetinal venous malformation associated with ipsilateral cerebral venous malformationEyeFeb 25 2026
Three-dimensional visualization of choroidal colobomaEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04341-3Three-dimensional visualization of choroidal colobomaEyeFeb 25 2026
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMDEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04319-1AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMDEyeFeb 25 2026
Characteristics of patients dismissed from a retina practiceEye, Published online: 25 February 2026; doi:10.1038/s41433-026-04332-4Characteristics of patients dismissed from a retina practiceEyeFeb 25 2026
Prevalence and patterns of anti-angiogenic treatment discontinuation in neovascular age-related macular degeneration—insights from health claims dataEye, Published online: 24 February 2026; doi:10.1038/s41433-026-04333-3Prevalence and patterns of anti-angiogenic treatment discontinuation in neovascular age-related macular degeneration—insights from health claims dataEyeFeb 24 2026
Feasibility and reproducibility of handheld and table-mounted optical coherence tomography in children with craniosynostosisEye, Published online: 24 February 2026; doi:10.1038/s41433-026-04317-3Feasibility and reproducibility of handheld and table-mounted optical coherence tomography in children with craniosynostosisEyeFeb 24 2026
Improving glaucoma referrals in Scotland: developing a national data set for referral from community optometry to the Hospital Eye Service (HES)Eye, Published online: 24 February 2026; doi:10.1038/s41433-026-04347-xImproving glaucoma referrals in Scotland: developing a national data set for referral from community optometry to the Hospital Eye Service (HES)EyeFeb 24 2026
Comparison of portable devices with standard glaucoma diagnostic testing for the detection of glaucoma for the purposes of glaucoma case finding in low-and middle- income countriesEye, Published online: 23 February 2026; doi:10.1038/s41433-026-04297-4Comparison of portable devices with standard glaucoma diagnostic testing for the detection of glaucoma for the purposes of glaucoma case finding in low-and middle- income countriesEyeFeb 23 2026
Infographic: ranibizumab for neovascular age-related macular degeneration: the MARINA studyEye, Published online: 23 February 2026; doi:10.1038/s41433-026-04348-wInfographic: ranibizumab for neovascular age-related macular degeneration: the MARINA studyEyeFeb 23 2026
Comment on: ‘Association between visual impairment and sleep quality: a cross-sectional, comparative study of severity, eye conditions, and risk factors’Eye, Published online: 23 February 2026; doi:10.1038/s41433-026-04328-0Comment on: ‘Association between visual impairment and sleep quality: a cross-sectional, comparative study of severity, eye conditions, and risk factors’EyeFeb 23 2026
Complications after radiotherapy in patients with Graves’ orbitopathy: A nationwide cohort studyEye, Published online: 21 February 2026; doi:10.1038/s41433-026-04284-9Complications after radiotherapy in patients with Graves’ orbitopathy: A nationwide cohort studyEyeFeb 21 2026
Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in USEye, Published online: 21 February 2026; doi:10.1038/s41433-026-04326-2Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in USEyeFeb 21 2026
Comment on: ‘Selective laser trabeculoplasty (SLT) outcomes following topical therapy’Eye, Published online: 20 February 2026; doi:10.1038/s41433-026-04359-7Comment on: ‘Selective laser trabeculoplasty (SLT) outcomes following topical therapy’EyeFeb 20 2026
Epidemiology and risk factors for corneal blindness in China: a multicentre retrospective study of 15,937 inpatientsEye, Published online: 20 February 2026; doi:10.1038/s41433-026-04311-9Epidemiology and risk factors for corneal blindness in China: a multicentre retrospective study of 15,937 inpatientsEyeFeb 20 2026
Ophthalmic screening in down syndrome: A DSMIG UK Best practice recommendation (Revised 2025)Eye, Published online: 20 February 2026; doi:10.1038/s41433-026-04310-wOphthalmic screening in down syndrome: A DSMIG UK Best practice recommendation (Revised 2025)EyeFeb 20 2026
Drug-induced corneal oedema: amantadine-associated toxicityEye, Published online: 20 February 2026; doi:10.1038/s41433-026-04340-4Drug-induced corneal oedema: amantadine-associated toxicityEyeFeb 20 2026
Bilateral symmetric lower eyelid multinucleate cell angiohistiocytomasEye, Published online: 20 February 2026; doi:10.1038/s41433-026-04322-6Bilateral symmetric lower eyelid multinucleate cell angiohistiocytomasEyeFeb 20 2026
Infographic: Teprotumumab for thyroid-associated ophthalmopathyEye, Published online: 20 February 2026; doi:10.1038/s41433-026-04336-0Infographic: Teprotumumab for thyroid-associated ophthalmopathyEyeFeb 20 2026
Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysisEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04331-5Differentiation of macular atrophy secondary to neovascular age-related macular degeneration vs. de novo geographic atrophy: a multimodal analysisEyeFeb 19 2026
Focal scleral nodule presenting as a depigmented lesionEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04299-2Focal scleral nodule presenting as a depigmented lesionEyeFeb 19 2026
Vitreous seeding in metastatic cutaneous melanomaEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04315-5Vitreous seeding in metastatic cutaneous melanomaEyeFeb 19 2026
Peripheral vascular scorching with posterior pole ember glow—hyperacute outer retinal dysfunctionEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04312-8Peripheral vascular scorching with posterior pole ember glow—hyperacute outer retinal dysfunctionEyeFeb 19 2026
Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusionEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04246-1Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusionEyeFeb 19 2026
Correlation between blood glucose levels and endophthalmitis risk after intravitreal injections of anti-vascular endothelial growth factorEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04303-9Correlation between blood glucose levels and endophthalmitis risk after intravitreal injections of anti-vascular endothelial growth factorEyeFeb 19 2026
Dropless cataract surgery: comparing sub-Tenon’s and topical steroids for postoperative inflammation prophylaxisEye, Published online: 19 February 2026; doi:10.1038/s41433-026-04309-3Dropless cataract surgery: comparing sub-Tenon’s and topical steroids for postoperative inflammation prophylaxisEyeFeb 19 2026
Smoking and idiopathic intracranial hypertension: a meta-analysisEye, Published online: 18 February 2026; doi:10.1038/s41433-026-04282-xSmoking and idiopathic intracranial hypertension: a meta-analysisEyeFeb 18 2026
A new era of efficiency: artificial intelligence scribes and the future of ophthalmologyEye, Published online: 18 February 2026; doi:10.1038/s41433-026-04346-yA new era of efficiency: artificial intelligence scribes and the future of ophthalmologyEyeFeb 18 2026
Comment on: ‘Incidence and prevalence of mucous membrane pemphigoid with ocular involvement: a retrospective analysis using the TriNetX database’Eye, Published online: 18 February 2026; doi:10.1038/s41433-026-04355-xComment on: ‘Incidence and prevalence of mucous membrane pemphigoid with ocular involvement: a retrospective analysis using the TriNetX database’EyeFeb 18 2026
Response to ‘Comment on: ‘Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation”Eye, Published online: 18 February 2026; doi:10.1038/s41433-026-04351-1Response to ‘Comment on: ‘Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation”EyeFeb 18 2026
The progressive journey of poor-responder neovascular AMD: tracking structural evolution and visual decline over timeEye, Published online: 17 February 2026; doi:10.1038/s41433-026-04306-6The progressive journey of poor-responder neovascular AMD: tracking structural evolution and visual decline over timeEyeFeb 17 2026
Variations in prevalence of retinopathy of prematurity (ROP) and completeness of screening in five units within a South African region: a register-based studyEye, Published online: 17 February 2026; doi:10.1038/s41433-026-04257-yVariations in prevalence of retinopathy of prematurity (ROP) and completeness of screening in five units within a South African region: a register-based studyEyeFeb 17 2026
Changing practice of macular hole surgery in the UK (2017–2024)Eye, Published online: 17 February 2026; doi:10.1038/s41433-025-04238-7Changing practice of macular hole surgery in the UK (2017–2024)EyeFeb 17 2026
Response to: ‘Comment on: ‘Association between visual impairment and sleep quality: A cross-sectional, comparative study of severity, eye conditions, and risk factors”Eye, Published online: 17 February 2026; doi:10.1038/s41433-026-04330-6Response to: ‘Comment on: ‘Association between visual impairment and sleep quality: A cross-sectional, comparative study of severity, eye conditions, and risk factors”EyeFeb 17 2026
Video-Indirect Fluorescein Angiofusion (VIFA): an emerging imaging technique for retinal vasculatureEye, Published online: 17 February 2026; doi:10.1038/s41433-026-04320-8Video-Indirect Fluorescein Angiofusion (VIFA): an emerging imaging technique for retinal vasculatureEyeFeb 17 2026
Distribution of and factors associated with intraocular pressure in school-age Chinese children: findings from a large-scale longitudinal studyEye, Published online: 17 February 2026; doi:10.1038/s41433-026-04305-7Distribution of and factors associated with intraocular pressure in school-age Chinese children: findings from a large-scale longitudinal studyEyeFeb 17 2026
Towards an objective classification of pachychoroid disease and its risk of progressionEye, Published online: 16 February 2026; doi:10.1038/s41433-026-04286-7Towards an objective classification of pachychoroid disease and its risk of progressionEyeFeb 16 2026
Correction: The ophthalmologist’s guide to clinical practice guidelines: the GRADE evidence-to-decision frameworks and GRADE-adolopmentEye, Published online: 16 February 2026; doi:10.1038/s41433-026-04252-3Correction: The ophthalmologist’s guide to clinical practice guidelines: the GRADE evidence-to-decision frameworks and GRADE-adolopmentEyeFeb 16 2026
Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)Eye, Published online: 16 February 2026; doi:10.1038/s41433-026-04321-7Infographic: five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (DRCR Protocol T Extension Study)EyeFeb 16 2026
Plasma metabolomics reveals distinct metabolic alterations and biomarkers of disease activity in HLA-B27-positive acute anterior uveitisEye, Published online: 14 February 2026; doi:10.1038/s41433-026-04307-5Plasma metabolomics reveals distinct metabolic alterations and biomarkers of disease activity in HLA-B27-positive acute anterior uveitisEyeFeb 14 2026
In vivo confocal microscopy findings from full corneal epithelial debridement and local corticosteroid for recurrent corneal erosionEye, Published online: 14 February 2026; doi:10.1038/s41433-026-04308-4In vivo confocal microscopy findings from full corneal epithelial debridement and local corticosteroid for recurrent corneal erosionEyeFeb 14 2026
Pseudopodia lentis and preretinal deposit in systemic amyloidosisEye, Published online: 13 February 2026; doi:10.1038/s41433-026-04259-wPseudopodia lentis and preretinal deposit in systemic amyloidosisEyeFeb 13 2026
Type 1 macular neovascularisation associated with choroidal artery compressionEye, Published online: 13 February 2026; doi:10.1038/s41433-026-04291-wType 1 macular neovascularisation associated with choroidal artery compressionEyeFeb 13 2026
Ultra–high-resolution visualisation of the human ciliary body using Hierarchical Phase-Contrast Tomography (HiP-CT)Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04300-yUltra–high-resolution visualisation of the human ciliary body using Hierarchical Phase-Contrast Tomography (HiP-CT)EyeFeb 13 2026
Comment on: “Ophthalmic complications associated with COVID-19: a large US national database analysis”Eye, Published online: 13 February 2026; doi:10.1038/s41433-026-04290-xComment on: “Ophthalmic complications associated with COVID-19: a large US national database analysis”EyeFeb 13 2026
An educational figure of nystagmusEye, Published online: 13 February 2026; doi:10.1038/s41433-026-04294-7An educational figure of nystagmusEyeFeb 13 2026
Tubercular serpiginous-like choroiditisEye, Published online: 11 February 2026; doi:10.1038/s41433-026-04293-8Tubercular serpiginous-like choroiditisEyeFeb 11 2026
Comment on: ‘Management of uveitic and chorioretinal conditions in pregnancy’Eye, Published online: 11 February 2026; doi:10.1038/s41433-026-04301-xComment on: ‘Management of uveitic and chorioretinal conditions in pregnancy’EyeFeb 11 2026
Three-dimensional choroidal vessels assessment in age-related macular degeneration: a follow-up studyEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04296-5Three-dimensional choroidal vessels assessment in age-related macular degeneration: a follow-up studyEyeFeb 10 2026
OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmologyEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04283-wOphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmologyEyeFeb 10 2026
Association between PCSK9 inhibitor use and risk of age-related macular degenerationEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04287-6Association between PCSK9 inhibitor use and risk of age-related macular degenerationEyeFeb 10 2026
Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusionEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04298-3Comparative effectiveness of varying hyperbaric oxygen protocols in the treatment of acute central retinal artery occlusionEyeFeb 10 2026
Selective laser trabeculoplasty: adverse effects of prior topical anti-glaucoma medicationEye, Published online: 10 February 2026; doi:10.1038/s41433-026-04273-ySelective laser trabeculoplasty: adverse effects of prior topical anti-glaucoma medicationEyeFeb 10 2026
Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implicationsEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04288-5Diabetic macular atrophy, a pilot exploration of its characteristics, progression, and visual implicationsEyeFeb 09 2026
Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye StudyEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04269-8Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye StudyEyeFeb 09 2026
Beyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathyEye, Published online: 09 February 2026; doi:10.1038/s41433-026-04272-zBeyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathyEyeFeb 09 2026
Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04240-7Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsEyeFeb 06 2026
Early vitrectomy for myopic foveoschisis before foveal detachmentEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04261-2Early vitrectomy for myopic foveoschisis before foveal detachmentEyeFeb 06 2026
Trocar sleeve adapter accelerates silicone oil injection in real-world vitreoretinal surgeryEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04279-6Trocar sleeve adapter accelerates silicone oil injection in real-world vitreoretinal surgeryEyeFeb 06 2026
Impact of multiple births on retinopathy of prematurity in preterm infantsEye, Published online: 06 February 2026; doi:10.1038/s41433-026-04247-0Impact of multiple births on retinopathy of prematurity in preterm infantsEyeFeb 06 2026
Hyperreflective choroidal foci may predict pachychoroid macular atrophy development in central serous chorioretinopathyEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04277-8Hyperreflective choroidal foci may predict pachychoroid macular atrophy development in central serous chorioretinopathyEyeFeb 05 2026
Neurotrophic keratopathy in childhood: advances in understanding of pathogenesis and managementEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04278-7Neurotrophic keratopathy in childhood: advances in understanding of pathogenesis and managementEyeFeb 05 2026
Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04274-xBiologic therapy is associated with reduced ocular disease in psoriasis: a real-world studyEyeFeb 05 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G &gt; A <i>MT-ND4</i> Leber optic neuropathy (REFLECT Trial)Eye, Published online: 05 February 2026; doi:10.1038/s41433-026-04266-xInfographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)EyeFeb 05 2026
Pigmentary retinopathy, oculomotor apraxia and esotropia: a widespread and intense ocular involvement in congenital glycosylation defectEye, Published online: 05 February 2026; doi:10.1038/s41433-026-04268-9Pigmentary retinopathy, oculomotor apraxia and esotropia: a widespread and intense ocular involvement in congenital glycosylation defectEyeFeb 05 2026
Leveraging structured EMR data for efficient patient prescreening: a practical approach to reducing screen-failure rates in Light Touch TrialEye, Published online: 04 February 2026; doi:10.1038/s41433-026-04267-wLeveraging structured EMR data for efficient patient prescreening: a practical approach to reducing screen-failure rates in Light Touch TrialEyeFeb 04 2026
Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedemaEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04271-0Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedemaEyeFeb 03 2026
Surgical management of aqueous misdirection by endoscopic vitrectomy with Hyaloido-Zonulo-IridectomyEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04265-ySurgical management of aqueous misdirection by endoscopic vitrectomy with Hyaloido-Zonulo-IridectomyEyeFeb 03 2026
Exposure of the Supramid suture—an uninvited disasterEye, Published online: 03 February 2026; doi:10.1038/s41433-026-04275-wExposure of the Supramid suture—an uninvited disasterEyeFeb 03 2026
Proposed Idiopathic Multiple Retinal Telangiectasias (IMRT)Eye, Published online: 03 February 2026; doi:10.1038/s41433-026-04276-9Proposed Idiopathic Multiple Retinal Telangiectasias (IMRT)EyeFeb 03 2026
Infographic: bevacizumab eliminates the angiogenic threat of retinopathy of prematurity (BEAT-ROP study)Eye, Published online: 03 February 2026; doi:10.1038/s41433-026-04285-8Infographic: bevacizumab eliminates the angiogenic threat of retinopathy of prematurity (BEAT-ROP study)EyeFeb 03 2026
Pickleball Players’ Reported Use of Protective EyewearThis survey study evaluates protective eyewear use among pickleball players.JAMA Ophthalmology Online FirstFeb 26 2026
Hyperacute Outer Retinal Dysfunction in a ChildThis case report discusses hyperacute outer retinal dysfunction in a child with long-term follow-up.JAMA Ophthalmology Online FirstFeb 26 2026
Prompt Validation in Large Language Models for Ophthalmology Education—ReplyIn Reply We appreciate both the responses by Kameda et al and Bair to our recent work. In clarification to Kameda and colleagues, we outline below the step-by-step process used to construct the survey.JAMA Ophthalmology Online FirstFeb 26 2026
Prompt Validation in Large Language Models for Ophthalmology EducationTo the Editor Gholami et al showed that Generative Pre-trained Transformer 4 (GPT-4; OpenAI)–class large language models (LLMs) can generate ophthalmology board-style multiple-choice questions that experts rated comparably with committee-authored items (median, 9 of 10 across domains), with moderate overall interrater reliability (intraclass correlation coefficient, 0.63; 95% CI, 0.58-0.67) and low lexical overlap with the…JAMA Ophthalmology Online FirstFeb 26 2026
Prompt Validation in Large Language Models for Ophthalmology EducationTo the Editor We read with great interest the article by Gholami et al evaluating the ability of Generative Pre-trained Transformer 4 (GPT-4; OpenAI) to generate ophthalmology board-style multiple-choice questions (MCQs). As researchers studying the reproducibility of large language models (LLMs) in medicine, we strongly support the role of artificial intelligence (AI) in medical education.…JAMA Ophthalmology Online FirstFeb 26 2026
Generalizability in OCT Deep Learning—Moving Beyond Single-Disease and Single-Vendor ModelsThe rapid evolution of artificial intelligence (AI) has enormous potential applications in ophthalmology, yet adaptation into broader clinical practice has lagged behind. Multiple factors contribute to this gap, one being limited generalizability. While many deep learning (DL) models often demonstrate expert-level performance in disease detection and classification, they can falter when generalized to different patient…JAMA Ophthalmology Online FirstFeb 26 2026
Just Ask—Recentering Human Communication in Medication AdherenceMedication nonadherence remains one of the most persistent and consequential challenges in chronic disease management. In glaucoma, reported nonadherence rates range from 5% to 80%, and patients who do not take topical medications as prescribed consistently experience worse visual outcomes. Against this backdrop, Newman-Casey and colleagues conducted a randomized clinical trial evaluating a motivational interviewing-based…JAMA Ophthalmology Online FirstFeb 26 2026
Conjunctival Lymphangiectasia With Intracystic HemorrhageThis case report discusses spontaneous intracystic hemorrhage in a conjunctival lymphangiectasia diagnosed in a female patient aged 36 years with a 1-year history of a left eye conjunctival vesicle.JAMA Ophthalmology Online FirstFeb 26 2026
Domain-Shift AI Technology for Vendor-Agnostic Multiple Macular Disease Detection From 3D OCT ScansThis multicenter cohort study develops a vendor-agnostic artificial intelligence (AI) model for multidisease classification using 3-dimensional (3D) optical coherence tomography (OCT) scans from different vendors.JAMA Ophthalmology Online FirstFeb 26 2026
Support, Educate, Empower Program and Medication AdherenceThis randomized clinical trial compares the use of the Support, Educate, Empower program with standard of care for medication adherence.JAMA Ophthalmology Online FirstFeb 26 2026
Incremental Carbon Footprint Effectiveness Ratio in OphthalmologyThis Viewpoint describes the incremental carbon footprint effectiveness ratio (ICFER) as a measure to assess the environmental impact of interventions in terms of carbon footprint per quality-adjusted life-year.JAMA Ophthalmology Online FirstFeb 19 2026
Fuchs Endothelial Corneal DystrophyThis post hoc secondary analysis of the Women’s Health Initiative study assesses whether randomization to hormone therapy use was associated with subsequent incident Fuchs endothelial corneal dystrophy.JAMA Ophthalmology Online FirstFeb 19 2026
Ultra-Widefield OCTA in Leukemic Optic InfiltrationThis case report discusses the detailed visualization using optical coherence tomography angiography (OCTA) of vascular abnormalities over the optic disc in the setting of B-cell lymphoblastic leukemia.JAMA Ophthalmology Online FirstFeb 19 2026
Error in BylineIn the Brief Report titled “Pharmacologic Inhibition of YAP/TEAD and Development of New Chorioretinal Atrophy,” published online December 4, 2025, and in the January 2026 issue, one of the authors did not have a middle initial in the byline. The author’s name is Edward S. Lu. The article was corrected online.JAMA Ophthalmology Online FirstFeb 19 2026
Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular DegenerationThis post hoc analysis of the TENAYA and LUCERNE randomized clinical trials investigates whether rapid drying with faricimab, specifically intraretinal fluid and subretinal fluid resolution through week 12, is associated with later treatment durability.JAMA Ophthalmology Online FirstFeb 19 2026
Ocular Manifestations of Biopsy-Proven B Virus Infection With Central Nervous System InvolvementThis case report describes a patient with B virus infection with clinical features including severe central nervous system dysfunction and bilateral panuveitis.JAMA Ophthalmology Online FirstFeb 19 2026
Thyroid Eye Disease and the Prevalence of Human PapillomavirusThis case-control study examines human papillomavirus and thyroid eye disease data from a large-scale centralized electronic health record database network.JAMA Ophthalmology Online FirstFeb 12 2026
Bisphosphonate-Associated Orbital InflammationThis case report describes a diagnosis of preseptal and orbital inflammation after intravenous infusion of the bisphosphonate zoledronate for osteoporosis in a woman aged 64 years.JAMA Ophthalmology Online FirstFeb 12 2026
New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 DiabetesThis observational study emulates a target trial evaluating the risk of NAION associated with initiation of semaglutide, compared with a sodium-glucose cotransporter-2 inhibitor as second-line therapy for type 2 diabetes in a nationwide cohort of US veterans.JAMA Ophthalmology Online FirstFeb 12 2026
Iris Trabecular Contact on OCT in Angle Closure ProgressionThis cohort study investigates the association between iridotrabecular contact on anterior segment optical coherence tomography images and risk of 72-month progression from primary angle closure suspect to primary angle closure.JAMA Ophthalmology Online FirstFeb 05 2026
Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract SurgeryThis cohort study examines the association between cataract surgery and progression of age-related macular degeneration in adults 60 years or older.JAMA Ophthalmology Online FirstFeb 05 2026
Corneal Abrasion Leading to Stromal Melt in a Patient With MyopiaThis case report describes an incidence of corneal melt in a patient with a history of corneal insert implantation 26 years prior due to myopia.JAMA Ophthalmology Online FirstFeb 05 2026
Safety Evaluation of 4 Red Light Therapy Devices for MyopiaThis quality improvement study assesses the optical output and safety classification of 4 commercially available red light therapy devices for myopia management using American National Standards Institute guidelines.JAMA Ophthalmology Online FirstFeb 05 2026

© ECM All rights reserved 2026.